# Hikma Pharmaceuticals USA, Inc.: Cefotaxime Sodium Powder, for Solution shortage reverified (unavailable from this maker)

**Score:** 45/100

| Field | Value |
|---|---|
| Manufacturer | Hikma Pharmaceuticals USA, Inc. |
| Drug | Cefotaxime Sodium Powder, for Solution |
| Dosage form | Powder, For Solution |
| Therapeutic category | Anti-Infective, Pediatric |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Unavailable |
| Reason | Demand increase for the drug |
| Presentations affected | 4 |
| Package NDCs | 0143-9935-01, 0143-9933-25, 0143-9930-10, 0143-9931-25 |
| Manufacturer supply note | Estimated recovery: TBD |
| First posted | 2015-02-17 |
| Updated | 2026-10-14 |

## Why this score
- Unavailable from this manufacturer.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.